GLP-1 vs GLP-3: What's Real and What's Confused

Direct Answer

GLP-1 vs GLP-3: what's real and what's confused? GLP-1 (glucagon-like peptide-1) is a real, established human hormone and medication pathway, used in FDA-approved drugs since 2005. "GLP-3" is not a real hormone your body produces, and it's not an official FDA drug class. It's an informal nickname people use for retatrutide, an investigational medication still in clinical trials.

Why the "GLP-3" Name Exists

Retatrutide is a triple hormone receptor agonist, it activates receptors for GLP-1, GIP, and glucagon at once, one step beyond tirzepatide's dual GLP-1/GIP action. The "third arm" is glucagon receptor activity, not a separate GLP-3 hormone. The nickname caught on informally because "triple agonist" doesn't roll off the tongue as easily as "GLP-3," but it's not terminology used by Eli Lilly, the FDA, or peer-reviewed medical journals.

What Retatrutide Actually Is

Retatrutide is developed by Eli Lilly, the same company behind Mounjaro and Zepbound. It remains investigational, not FDA-approved, currently in Phase 3 trials, with earliest realistic approval estimated around 2027, not confirmed. In trials, it has produced some of the largest weight-loss results seen with any obesity medication to date, participants on the highest dose lost an average of roughly 25% of body weight after 88 weeks in one trial.

A Real, Important Warning Sign

If a vendor or telehealth provider uses "GLP-3" as though it's an official, approved medication category to sell you a product, treat that as a real red flag, it's not accurate terminology, and retatrutide specifically cannot legally be compounded under federal law.

Bottom Line

If you're searching "GLP-1 vs GLP-3," you're most likely looking for information about retatrutide specifically, or about dual and triple agonist medications generally, not a genuinely separate hormone class. GLP-1 is real and established; "GLP-3" is a nickname, not a category.

References

• New England Journal of Medicine: Phase 2 retatrutide trial results (2023)
• Drugs.com: How Does Retatrutide Compare to Tirzepatide?
• Fox News: 'GLP-3' Retatrutide Drug Delivers Major Weight Loss Breakthrough in Trials

Related Resources

• Is Microdosing Retatrutide (GLP-3) Safe or Effective?
• Does Retatrutide (GLP-3) Cause Hair Loss?

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical advice.